Cerner (Nasdaq: CERN) is expected to report Q2 earnings on July 25. Here's what Wall Street wants to see:

The 10-second takeaway
 Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Cerner's revenues will expand 13.9% and EPS will expand 10.0%.

The average estimate for revenue is $725.7 million. On the bottom line, the average EPS estimate is $0.33.

Revenue details
 Last quarter, Cerner booked revenue of $680.0 million. GAAP reported sales were 5.7% higher than the prior-year quarter's $629.7 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 Last quarter, non-GAAP EPS came in at $0.33. GAAP EPS of $0.31 for Q1 were 19% higher than the prior-year quarter's $0.26 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
 For the preceding quarter, gross margin was 83.1%, 640 basis points better than the prior-year quarter. Operating margin was 23.5%, 330 basis points better than the prior-year quarter. Net margin was 16.5%, 240 basis points better than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $2.99 billion. The average EPS estimate is $1.38.

Investor sentiment
 The stock has a three-star rating (out of five) at Motley Fool CAPS, with 416 members out of 463 rating the stock outperform, and 47 members rating it underperform. Among 137 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 130 give Cerner a green thumbs-up, and seven give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Cerner is outperform, with an average price target of $46.49.

Is Cerner the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.